Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diagnotes was a U.S. digital health company that developed a HIPAA-compliant clinical communication and care coordination platform for hospitals, health systems, long-term care facilities, employers, and behavioral health organizations. Its software enabled secure messaging, provider-to-provider collaboration, patient communication, telehealth consults, and sharing of patient information and images across devices. The company focused on improving workflow efficiency, care-team coordination, and patient and provider satisfaction rather than developing therapeutics. In February 2023, DrFirst announced it had acquired select assets of Diagnotes, and the capabilities were folded into Backline by DrFirst. As a result, Diagnotes appears to no longer operate as an independent active company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diagnotes.